CDSCO approves HiMedia's latest COVID-19 testing products

31 January 2022 | News

To encourage smaller labs that cannot afford high-end automation

Central Drugs Standard Control Organization (CDSCO) has approved two more important COVID-19 testing products of HiGenoMB – HiMedia Laboratories.

In the Hi-PCR COVID-19 Detection Kit-Dry Swab method (MBT189), the extraction free method assesses dry swab samples and supports direct real-time PCR post sample collection. This is an ideal solution to encourage smaller laboratories that cannot afford high-end automation and reduces dependency on skilled technicians to venture into molecular diagnostics.

The Hi-PCR COVID-19 Triplex Probe PCR Kit (MBPCR255) is a three gene multiplex PCR kit that can detect two target COVID genes, viz. (N) gene and RNA-dependent RNA polymerase (RdRp) gene along with an internal process control with maximum sensitivity. It is an alternative to our CDSCO approved four gene Hi-PCR Coronavirus (COVID-19) Probe PCR Kit (MBPCR243).

Visit for more details about HiGenoMB® products related COVID Molecular testing.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account